ACTIVE

BIOGEN BELGIUM

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result1,6 M €-11,2 %over 1 year
Revenue84,7 M €-3,6 %over 1 year
Equity15,4 M €+11,9 %over 1 year
Workforce30,5 ETP-12,1 %over 1 year

Identity

Source · BCE/KBO

BIOGEN BELGIUM is a Public limited company incorporated in 1997. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Machelen (Brab.). It employs on average 30,5 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0462.285.469
Incorporation
29/12/1997
Legal form
Public limited company
Registered office
Culliganlaan 2
1831 Machelen (Brab.) · FlandreSee on map
Contributed capital
62 000,00 €
Latest accounts
31/12/2025
Average workforce
30,5 ETP
Joint committees (3)
  • 200
  • 2000
  • 218
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHigh revenue

Financials

Source · NBB, 21 filings

Trend over 21 financial years

20252024202320222021
Income statement
Revenue84,7 M €87,9 M €81,6 M €93,5 M €106,2 M €
EBITDA2,7 M €3 M €2,6 M €3,1 M €4,6 M €
Operating result2,7 M €3 M €2,6 M €3,1 M €4,6 M €
Net result1,6 M €1,9 M €1,6 M €1,9 M €2,9 M €
Balance sheet
Equity15,4 M €13,8 M €11,9 M €10,3 M €8,4 M €
Total assets25,5 M €26,3 M €24 M €25,7 M €35,5 M €
Cash16,4 M €15,4 M €14,7 M €14,6 M €22,8 M €
Debts10 M €12,5 M €12,1 M €15,3 M €27,1 M €
Other
Workforce30,5 ETP34,7 ETP38,5 ETP42,3 ETP44,8 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 25 M€ and 50 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 41 ended

Active mandates

Chris LAUWEREINS

Director · since 02 octobre 2025 · until 02 octobre 2031

Active
Sergio Ferreira da Silva Teixeira

Director · since 22 septembre 2023

Active
Francesco Verolino

Director · since 15 septembre 2022

Active
Olivier Zambelli

Director · since 01 août 2022 · until 09 mai 2025

Active

Ended mandates

Dorota Mazurkiewicz

Director · since 01 septembre 2022 · until 21 septembre 2023

Ended
Dorota Mazurkiewicz

Director · since 01 septembre 2022

Ended
Olivier Zambelli

Director · since 01 septembre 2022

Ended
Chris Maria G. LAUWEREINS

Director · since 02 octobre 2019 · until 01 octobre 2025

Ended

Other companies at this address

Culliganlaan 2 1831 Machelen (Brab.)
CompanyCBE no.
BENCIS CAPITAL PARTNERS BELGIUM● Active
0866.066.577
Boulevard Conference & Services● Active
0864.544.172
BOULEVARD TOWER● Active
0508.948.706
BrightWolves● Active
0684.826.235
CM Land● Active
0896.933.165
CM Towers● Active
0893.648.132
Digit Mint● Active
0793.961.430
GOVPROP● Active
0869.915.893
INSPIRE PARTNERSHIP● Active
0771.710.620
InVST● Active
0773.803.840
LA TOUR DE FAGNOLLES● Active
0888.064.395
Les Gets Invest● Active
1030.497.811
MITCHY● Active
0786.581.215
Proact Belgium● Active
0871.735.337
QUANTEUS GROUP● Active
0882.672.878
QuantIM● Active
0657.836.677
RSQ Partnership● Active
1019.476.928
September Partners● Active
1030.536.413
VERIZON TERREMARK● Active
0455.138.450

Full financial information

Source · NBB
202520242023202220212020
Type of accountFull modelFull modelFull modelFull modelFull modelFull model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date29/06/202610/07/202523/07/202411/07/202318/07/202225/06/2021
General meeting16/06/202617/06/202518/06/202420/06/202321/06/202215/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 21 filings
ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202516/06/202629/06/2026DutchPDF
Full model31/12/202417/06/202510/07/2025DutchPDF
Full model31/12/202318/06/202423/07/2024DutchPDF
Full model31/12/202220/06/202311/07/2023DutchPDF
Full model31/12/202121/06/202218/07/2022DutchPDF
Full model31/12/202015/06/202125/06/2021DutchPDF
Full model31/12/201916/06/202030/07/2020DutchPDF
Full model31/12/201818/06/201918/07/2019DutchPDF
Full model31/12/201719/06/201825/06/2018DutchPDF
Full model31/12/201620/06/201718/07/2017DutchPDF
Full model31/12/201521/06/201628/07/2016DutchPDF
Full model31/12/201430/06/201531/07/2015DutchPDF
Full model31/12/201304/07/201431/07/2014DutchPDF
Full model31/12/201230/07/201331/07/2013DutchPDF
Full model31/12/201119/06/201202/07/2012DutchPDF
Full model31/12/201030/06/201112/08/2011DutchPDF
Full model31/12/200921/06/201024/08/2010DutchPDF
Full model31/12/200829/06/200931/08/2009DutchPDF
Full model31/12/200720/06/200814/08/2008DutchPDF
Full model31/12/200626/10/200715/11/2007DutchPDF
Full model31/12/200529/06/200729/08/2007FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 25 M€ and 50 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

4 active · 41 ended

Active mandates

Chris LAUWEREINS

Director · since 02 octobre 2025 · until 02 octobre 2031

Active
Sergio Ferreira da Silva Teixeira

Director · since 22 septembre 2023

Active
Francesco Verolino

Director · since 15 septembre 2022

Active
Olivier Zambelli

Director · since 01 août 2022 · until 09 mai 2025

Active

Ended mandates

Dorota Mazurkiewicz

Director · since 01 septembre 2022 · until 21 septembre 2023

Ended
Dorota Mazurkiewicz

Director · since 01 septembre 2022

Ended
Olivier Zambelli

Director · since 01 septembre 2022

Ended
Chris Maria G. LAUWEREINS

Director · since 02 octobre 2019 · until 01 octobre 2025

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Other02/07/2026
    —
    PDF
  • Mandates13/05/2026
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates06/10/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates22/07/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other23/06/2025
    DIVERSEN
    PDF
  • Mandates02/06/2025
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other27/03/2024
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Other12/02/2024
    DIVERSEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 20251,6 M €↓
  2. 2024
    Annual accounts 20241,9 M €↑
  3. 2023
    Annual accounts 20231,6 M €↓
  4. 2022
    Annual accounts 20221,9 M €↓
  5. 2021
    Annual accounts 20212,9 M €↓
  6. 2020
    Annual accounts 20202,9 M €↑
  7. 2019
    Annual accounts 20192,5 M €↑
  8. 2018
    Annual accounts 20182,1 M €↑
  9. 2017
    Annual accounts 20171,7 M €↑
  10. 2016
    Annual accounts 20161,5 M €↑
  11. 2015
    Annual accounts 20151 M €↑
  12. 2014
    Annual accounts 2014925,2 k €↑
  13. 2014
    Name changeBiogen Belgium NV
  14. 2013
    Annual accounts 2013756,8 k €↑
  15. 2012
    Annual accounts 2012714,9 k €↓
  16. 2011
    Annual accounts 2011880,9 k €↓
  17. 2010
    Annual accounts 20101 M €↑
  18. 2009
    Annual accounts 2009989,6 k €↓
  19. 2008
    Annual accounts 20081,1 M €↑
  20. 2007
    Annual accounts 2007728,4 k €↓
  21. 2006
    Annual accounts 20061,1 M €↑
  22. 2005
    Annual accounts 2005962,3 k €
  23. 2005
    Name changebiogen idec belgium
  24. 29/12/1997
    IncorporationPublic limited company